MegaPro Biomedical MPB-1734 Receives Composition Patent for New Dosage Form of Anticancer Drug which enhanced the immune-combination therapy

DJ MegaPro Biomedical MPB-1734 Receives Composition Patent for New Dosage Form of Anticancer Drug which enhanced the immune-combination therapy EQS Newswire / 15/11/2022 / 10:41 UTC+8 MegaPro Biomedical

Related Keywords

Taiwan ,United States ,Industrial Technology Research Institute ,Kao Hsiung ,Kostenloser Wertpapierhandel ,Marketing Press ,Megapro Biomedical Receiving Compositional Patent ,Megapro Biomedical Co Ltd ,Composition Patent ,New Dosage Form ,Anticancer Drug ,Pro Biomedical ,Press Release ,Yuan Hung Hsu ,Executive Vice President ,Megapro Biomedical ,Industrial Technology Research ,Marketing Press Release ,Dow Jones Newswires ,Omegapro ,Iomedical ,4734 ,Eceives ,Composition ,Patent ,Dosage ,Form ,Anticancer ,Drug ,Which ,Nhanced ,Immune ,Combination ,Therapy ,